Can Imaging be an Alternative to Exercise Testing as a Predictor of Surgical Fitness?

NCT ID: NCT06544187

Last Updated: 2025-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

56 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-06

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to explore an alternative method for assessing a participant's readiness for surgery, specifically for those undergoing surgery for gastric, oesophageal, or pancreatic cancer. Surgery for these diseases is extremely demanding on the body and surgeons need to be confident that a patient can tolerate the procedure.

Traditionally, participants undergo Cardiopulmonary Exercise Tests (CPET) to determine their fitness for surgery. This involves cycling on an exercise bike with increasing resistance until the resistance is too great to continue cycling at a constant rate. An individual's maximum rate of oxygen consumption (VO2max) and the anaerobic threshold (AT) are calculated during CPET and used by surgeons as a predictor for surgical fitness. CPET tests can be physically demanding for participants and are very resource intensive. Furthermore, some patients may not be able to tolerate exercise tests due to physical constraints.

An alternative method, Magnetic Resonance Spectroscopy (MRS), could be used to measure an individual's fitness prior to surgery. Within this study, MRS will be used to determine the levels of fat within the thigh muscle, which in turn may be able to be used to predict fitness for surgery.

The first phase includes recruiting participants on the surgical pathway. MRS will be performed as an additional examination, typically on the same day as the CPET. Fat levels determined from MRS will be compared with conventional CPET outcomes (VO2max and AT). This analysis aims to determine if MRS derived fat levels correlates with VO2max and AT and, if correlation is high, potentially providing an alternative to CPET for patients who cannot tolerate exercise tests.

The second phase involves recruiting volunteers who will undergo repeated MRS scans to assess the reliability of MRS methods. This process allows us to understand the consistency of MRS derived fat levels over both short and long-term intervals.

The potential benefits of this project include an additional pathway for assessing fitness for surgery or enhancing the presurgical pathway for patients by providing an alternative method for fitness assessment. This study aims to provide evidence that could present an alternative method of assessing a patient's fitness for surgery. The goal is to explore an alternative that may complement or refine current practices in preoperative assessments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Fitness Imaging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants

The first phase of the study will involve 56 participants who are potential candidates for oesophagectomy, gastrectomy or pancreaticoduodenectomy procedures following a confirmed cancer diagnosis. Participants who provide their consent will undergo Magnetic Resonance Spectroscopy (MRS) scans of their semitendinosus muscle in the thigh. Participants on this pathway also undergo Cardiopulmonary Exercise Test (CPET) tests, which is a standard procedure. No delay to their normal treatment pathway will be introduced from the addition of the MRS scan, and MR scans can be arranged within two weeks from referral

MRS scan

Intervention Type DIAGNOSTIC_TEST

Magnetic Resonance Spectroscopy scan on the thigh

CPET

Intervention Type DIAGNOSTIC_TEST

Cardiopulmonary Exercise Test

Healthy volunteers

25 healthy volunteers. Their role will be to help us understand the consistency in Intra-Myocellular Liquid (IMCL) composition using Magnetic Resonance Spectroscopy (MRS) techniques. These volunteers will be sourced from the UHNM Trust staff, in accordance with Trust Standard Operating Procedure (SOP): The Safe Scanning of Volunteers in Magnetic Resonance Imagine (MRI). Each volunteer will undergo two MRS scans initially. All three MRS scans will be performed in a single session, with the session lasting about 20 minutes. Additionally, each volunteer will return for a single repeat session of MRS acquisition using the same MRI system and protocol, scheduled at two weeks after the initial scans

MRS scan

Intervention Type DIAGNOSTIC_TEST

Magnetic Resonance Spectroscopy scan on the thigh

CPET

Intervention Type DIAGNOSTIC_TEST

Cardiopulmonary Exercise Test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRS scan

Magnetic Resonance Spectroscopy scan on the thigh

Intervention Type DIAGNOSTIC_TEST

CPET

Cardiopulmonary Exercise Test

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed oesophageal/gastric or pancreatic cancer.
* Patients who have or a under consideration for a CPET investigation.
* Aged ≥ 18.
* Existing UHNM Patient.
* Willing and able to give fully informed consent.
* Willing and able to comply with the study procedures.


* Aged ≥ 18 years.
* Willing and able to give fully informed consent.
* Willing and able to comply with the study procedures.
* UHNM member of staff.

Exclusion Criteria

* Patients with contraindications to MRI due to safety at 3T.
* Patients with metalwork within the imaging field of view (e.g., knee replacement).
* Claustrophobic patients.
* Patients outside of stated age range to ensure informed consent.
* Patients not referred for CPET investigations.
* Patients that are pregnant.
* Patients that are unable to communicate in English.
* Patients lacking the capacity and capability to give fully informed consent.
* Patients participating in any other interventional studies with a contraindication to their participation.
* Patients for whom the addition of an MRS scan would delay any part of their standard treatment pathway.
* History of diabetes.


* Volunteers with contraindications to MRI due to safety at 3T.
* Volunteers with metalwork within the imaging field of view (e.g., knee replacement).
* Claustrophobic volunteers.
* Volunteers outside of stated age range to ensure informed consent.
* Volunteers that are pregnant.
* Volunteers that are unable to communicate in English.
* Volunteers lacking the capacity and capability to give fully informed consent.
* Volunteers participating in any other interventional studies with a contraindication to their participation.
* Known or suspected medical conditions pertinent to the area being scanned.
* History of diabetes.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospitals of North Midlands NHS Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals of North Midlands NHS Trust

Stoke-on-Trent, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aviva Ogbolosingha

Role: CONTACT

01782 675380

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aviva Ogbolosingha

Role: primary

01782 675380

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3354

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Taking AIM at Breast Cancer
NCT04720209 ACTIVE_NOT_RECRUITING NA